Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada
Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada
Recruiting · NCT07370766 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorder | Recruiting | Not stated | 2026-09-11 | NCT07370766 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chronicle Academy | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Benchmark Dermatology | Burlington | Canada | 1 |
| Elevate Dermatology | Pickering | Canada | 1 |
| Factor Dermatology | Ottawa | Canada | 1 |
| Locke Dermatology | Hamilton | Canada | 1 |
| Panorama Dermatology Clinic | Kanata | Canada | 1 |
| Saskatoon Dermatology Centre | Saskatoon | Canada | 2 |
| Vital Medical Centre | Ottawa | Canada | 1 |